Black Diamond Therapeutics Inc (BDTX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | RAMAN, PRAKASH | Director | Common Stock | Acquisition | 6,801 | 1.93 |
| Sep 18, 2026 | BEHBAHANI, ALI | Director | Common Stock | Acquisition | 7,707 | 1.93 |
| Jun 26, 2026 | CAMPBELL, SHANNON | Director | Stock Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jun 26, 2026 | DHINGRA, KAPIL | Director | Stock Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jun 26, 2026 | MENZEL, GARRY E | Director | Stock Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jun 26, 2026 | KULKARNI, SAMARTH | Director | Stock Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jun 26, 2026 | RAMAN, PRAKASH | Director | Stock Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jun 26, 2026 | BEHBAHANI, ALI | Director | Stock Option (Right to Buy) | Acquisition | 40,000 | 0 |
| Jun 19, 2026 | BEHBAHANI, ALI | Director | Common Stock | Acquisition | 8,961 | 1.66 |
| Jun 19, 2026 | RAMAN, PRAKASH | Director | Common Stock | Acquisition | 7,907 | 1.66 |
| Mar 20, 2026 | RAMAN, PRAKASH | Director | Common Stock | Acquisition | 6,105 | 2.15 |
| Mar 20, 2026 | BEHBAHANI, ALI | Director | Common Stock | Acquisition | 6,919 | 2.15 |
| Jan 21, 2026 | BUCK, ELIZABETH | CHIEF SCIENTIFIC OFFICER | Stock Option (Right to Buy) | Acquisition | 250,000 | 0 |
| Jan 21, 2026 | HATZIS-SCHOCH, BRENT | SEE REMARKS | Stock Option (Right to Buy) | Acquisition | 250,000 | 0 |
| Jan 21, 2026 | JONES, ERIKA | SEE REMARKS | Stock Option (Right to Buy) | Acquisition | 200,000 | 0 |
| Jan 21, 2026 | VELLECA, MARK A. | Director, PRESIDENT & CEO | Stock Option (Right to Buy) | Acquisition | 600,000 | 0 |
| Jan 21, 2026 | YURASOV, SERGEY | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | Acquisition | 250,000 | 0 |
| Dec 12, 2025 | RAMAN, PRAKASH | Director | Common Stock | Acquisition | 4,665 | 2.76 |
| Dec 12, 2025 | BEHBAHANI, ALI | Director | Common Stock | Acquisition | 5,208 | 2.76 |